OpenVSafe by OpenVAERS
Search V-safe

CMB-11413-50382

5 vaccinations 10 coded responses 49 check-ins 9 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
730 / OK
Registered
2021-01-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-22
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-25
    Registered in v-safe
  3. 2021-01-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus, Skin sensitisation — Feeling: Good
    Free text: Occasion itching on my face; sensitivity of skin
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus — Feeling: Good
    Free text: Still experiencing skin itching at times, no rash.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus, Sensitive skin — Feeling: Good
    Free text: Continued skin sensitivity, itchy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-29
    Survey response — day 7, dose 1
    MedDRA: Skin sensitisation — Feeling: Good
    Free text: Skin sensitivity is better this PM.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-02-12
    Dose 2 — Pfizer-BioNTech
  9. 2021-02-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  12. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-26
    Survey response — day 42, dose 2
    MedDRA: Abdominal discomfort, Headache — Feeling: Fair
    Free text: Upset stomach & headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-08-13
    Survey response — 6 months, dose 2
    MedDRA: Adverse reaction, Eye pruritus, Office visit, Respiratory tract congestion, Rhinorrhoea, Sneezing, Throat irritation — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Runny nose, itchy eyes & throat, sneezing, congestion - allergy like symptoms. · Healthcare visit (other): Visit to PA
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-08-13
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-08-23
  26. 2021-10-04
    Dose 3 — Pfizer-BioNTech
  27. 2022-02-12
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Gastrointestinal disorder, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Gallbladder removed Aug 24, 2021. Continued digestive issues. COVID booster October 4, 2021. Positive for coronavirus Jan 17, 2022.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-05-13
    Dose 4 — Pfizer-BioNTech
  29. 2022-05-14
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  30. 2022-05-15
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  31. 2022-05-16
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  32. 2022-05-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  33. 2022-05-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  34. 2022-05-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  35. 2022-05-20
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  36. 2022-05-27
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-06-03
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-06-10
    Survey response — day 28, dose 4
    MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Stuffy head, symptoms of a head cold
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-06-17
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  40. 2022-06-24
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-08-12
    Survey response — 3 months, dose 4
    MedDRA: Gastrointestinal disorder, Hepatic enzyme increased — Feeling: Good
    Free text: Digestive issues - elevated liver enzymes
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-10-19
    Dose 5 — Pfizer-BioNTech
  43. 2022-10-19
    Health check-in — day 0, dose 5
    Feeling: Good · None
    Adult check-in
  44. 2022-10-20
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  45. 2022-10-21
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  46. 2022-10-22
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  47. 2022-10-23
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  48. 2022-10-24
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  49. 2022-10-25
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  50. 2022-10-26
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  51. 2022-11-02
    Health check-in — day 14, dose 5
    Feeling: Fair
    Adult check-in
  52. 2022-11-09
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  53. 2022-11-16
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  54. 2022-11-23
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  55. 2022-11-30
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  56. 2023-01-18
    Survey response — 3 months, dose 5
    MedDRA: Raynaud's phenomenon — Feeling: Fair
    MedDRA releases: 2024-11
  57. 2023-04-19
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-22Pfizer-BioNTech
22021-02-12Pfizer-BioNTech
32021-10-04Pfizer-BioNTech No
42022-05-13Pfizer-BioNTech No
52022-10-19Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-26

Systemic reaction (other): Occasion itching on my face; sensitivity of skin

2021-01-27

Systemic reaction (other): Still experiencing skin itching at times, no rash.

Release 3 — days 1–6 daily, dose 1

2021-01-28

Systemic reaction (other): Continued skin sensitivity, itchy

Release 3 — day 7, dose 1

2021-01-29

Systemic reaction (other): Skin sensitivity is better this PM.

Release 6 — day 42, dose 2

2021-03-26

Symptoms: Upset stomach & headache

Release 9 — 6 months, dose 2

2021-08-13

Symptoms: Runny nose, itchy eyes & throat, sneezing, congestion - allergy like symptoms.
Healthcare visit (other): Visit to PA

Release 11 — 12 months, dose 2

2022-02-12

Symptoms: Gallbladder removed Aug 24, 2021. Continued digestive issues. COVID booster October 4, 2021. Positive for coronavirus Jan 17, 2022.

Release 12 — day 28, dose 4

2022-06-10

Symptoms: Stuffy head, symptoms of a head cold

Release 12 — 3 months, dose 4

2022-08-12

Symptoms: Digestive issues - elevated liver enzymes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ · ✓
SDAbdominal discomfort ✓ ✓ ✓
SDAdverse reaction ✓ · ✓
SDCOVID-19 · · ✓
SDEye pruritus ✓ · ✓
SDGastrointestinal disorder · · ✓
SDHeadache ✓ ✓ ✓
SDHepatic enzyme increased · · ✓
SDNasopharyngitis · · ✓
SDPre-existing disease · · ✓
SDRaynaud's phenomenon · · ✓
SDRespiratory tract congestion ✓ · ✓
SDRhinorrhoea ✓ · ✓
SDSneezing ✓ · ✓
SDThroat irritation ✓ · ✓
SROPruritus ✓ ✓ ✓
SROSensitive skin ✓ ✓ ✓
SROSkin sensitisation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release